13 February 2012 - Acorda Therapeutics Inc (NASDAQ:ACOR) on Monday announced that it has appointed Jane Wasman as chief, strategic development.

In this new role Wasman will oversee the development and execution of the company’s long-range strategic plans and objectives and for the a...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up